ZEN Share Price Performance

ZEN Community Fair Values

View all narratives

Recent ZEN News & Updates

No updates

Zentek Ltd. Key Details

Last Reported Earnings

Mar 31, 2025

Next Reporting Earnings

n/a

Earnings per share (EPS): -0.096
Gross Margin: 16.54%
Net Profit Margin: -1,150.68%
Debt/Equity Ratio: 2.4%

View full report ›

Zentek Ltd. Competitors

About ZEN

Founded: 2008
Employees: 17
CEO: Gregory Fenton
WebsiteView website: www.zentek.com

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coatings under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing aptamers and rapid detection; and graphene oxide synthesis and graphene synthesis. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Canadian Market Performance

0.3%

13.4%

16.9%

9.1%

The Healthcare sector gained 5.7% while the market remained flat over the last week. More promisingly, the market is up 18% over the past year. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›

Zentek Stock Price

ZEN Share Price Performance

ZEN Community Fair Values

Recent ZEN News & Updates

Zentek Ltd. Key Details

Zentek Ltd. Competitors

Jack Nathan Medical

Evome Medical Technologies

Aurora Spine

MyndTec

Cloud DX

Aleen

Vibe Growth

Optimind Pharma

The Big Beautiful Deficit

🎢 From Panic to Peak: Q2’s Wild Ride and What’s Next